Гърция - гръцки - Εθνικός Οργανισμός Φαρμάκων

itf hellas ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΤΑΙΡΕΙΑ Δ.Τ. itf hellas s.a. Αρεως 103 & Αγίας Τριάδος 36,, 175 62 17562, Π. Φάληρο 210.9373332 - iron protein succinylate; calcium folinate pentahydrate - ps.or.sol (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ) - (800mg+0,185mg)/dose - iron protein succinylate 800mg; calcium folinate pentahydrate 0,235mg - various combinations

Кипър - гръцки - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

itf hellas a.e. - iron proteinsuccinylate - oral solution - 800(40fe)mg/15ml - 8000001419 - iron proteinsuccinylate - 53.33 mg - ferric proteinsuccinylate

Кипър - гръцки - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

beacon pharmaceuticals limited (0000010730) dcc vital westminster industrial estate, repton road, measham, swadlincote, de12 7dt - gelatin succinylated - solution for infusion - 4g/100ml - gelatin succinylated (8000000317) 4g - gelatin agents

Кипър - гръцки - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

itf hellas a.e. (0000008180) areos 103 and agias triados 36, palaio faliro, 17562 - iron proteinsuccinylate; calcium folinate pentahydrate - powder and solvent for oral solution - iron proteinsuccinylate (8000001419) 800mg; calcium folinate pentahydrate (0041927893) 0,235mg - iron in combination with folic acid

Гърция - гръцки - Εθνικός Οργανισμός Φαρμάκων

dr. willmar schwabe gmbh & co kg, germany 4, willmar-schwabe-strasse, d-76227 karlsruhe - lavandula angustifolia miller, aetheroleum - soft.caps (ΚΑΨΑΚΙΟ, ΜaΛΑΚΟ) - 80mg/cap - lavandula angustifolia miller, aetheroleum 80mg - lavandula angustifolia miller, aetheroleum

Кипър - гръцки - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

sanofi pasteur. (0000010487) 14 espace henry vallee, lyon, 69007 - diphtheria toxoid; poliomyelitis virus type 3; tetanus toxoid; pertussis toxoid(pt); filamentous haemagglutinin (fha); poliomyelitis virus type 2; poliomyelitis virus type 1; haemophilus infl. type b polys.conj.t.toxoid - powder & suspension for suspension for injection - diphtheria toxoid (8000000804) 0iu; poliomyelitis virus type 3 (8000000485) 32du; tetanus toxoid (8000040440) 0iu; pertussis toxoid(pt) (8000001811) 25mcg; filamentous haemagglutinin (fha) (8000001813) 25mcg; poliomyelitis virus type 2 (8000000484) 8du; poliomyelitis virus type 1 (8000000483) 40du; haemophilus infl. type b polys.conj.t.toxoid (8000001810) 10mcg - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus

Кипър - гръцки - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

sanofi pasteur. (0000010487) 14 espace henry vallee, lyon, 69007 - haemophilus influenzae typ b polysaccharid - powder & solvent for solution for injection - 10mcg/0.5ml - haemophilus influenzae typ b polysaccharid (8000031698) 10ug - hemophilus influenza b, purified antig.conjugated

Гърция - гръцки - Εθνικός Οργανισμός Φαρμάκων

uni-pharma ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ 14 ΧΛΜ. ΕΘΝ. ΟΔΟΥ ΑΘΗΝΩΝ-ΛΑΜΙΑΣ, 14564 Κ.ΚΗΦΙΣΙΑ 8072534 8072512 - iron protein acetyl aspartilate - oral.sol (ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ) - 800mg (equal to fe+++ 40mg)/15ml vial - iron protein acetyl aspartilate 800mg - ferric proteinsuccinylate

Европейски съюз - гръцки - EMA (European Medicines Agency)

ceva santé animale - αδρανοποιημένο εμβόλιο coxiella burnetii, στέλεχος nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

Кипър - гръцки - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - leflunomide - film coated tablets - 20mg - leflunomide (0075706126) 20mg - leflunomide